Surgimab

2 clinical trials · Sponsor

Record	Firm	Date
Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer (NCT03659448)	Surgimab	2019-06-17
Phase I of SGM-101 in Patients With Cancer of the Colon, Rectum or Pancreas (NCT02973672)	Surgimab	2016-01-01

Every clearance here is in the API, with alerts when new ones post.